Avantax Advisory Services’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Avantax Advisory Services’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$392K	Sell	4,723 -2,401	-34%	-$192K	﹤0.01%	1730
2025 Q1	$578K	Sell	7,124 -30	-0.4%	-$2.68K	﹤0.01%	1414
2024 Q4	$644K	Buy	7,154 +384	+6%	+$37.2K	﹤0.01%	1295
2024 Q3	$669K	Sell	6,770 -288	-4%	-$28.3K	﹤0.01%	1236
2024 Q2	$654K	Sell	7,058 -2,561	-27%	-$230K	﹤0.01%	1202
2024 Q1	$913K	Buy	9,619 +1,415	+17%	+$131K	0.01%	788
2023 Q4	$733K	Sell	8,204 -5,625	-41%	-$418K	0.01%	832
2023 Q3	$1.01M	Sell	13,829 -4,932	-26%	-$394K	0.01%	688
2023 Q2	$1.56M	Sell	18,761 -1,561	-8%	-$131K	0.02%	535
2023 Q1	$1.55M	Sell	20,322 -11,651	-36%	-$967K	0.02%	517
2022 Q4	$2.65M	Sell	31,973 -5,917	-16%	-$479K	0.04%	353
2022 Q3	$3M	Buy	37,890 +8,590	+29%	+$724K	0.05%	299
2022 Q2	$2.18M	Buy	29,300 +1,935	+7%	+$145K	0.03%	358
2022 Q1	$2.47M	Buy	27,365 +12,363	+82%	+$1.14M	0.03%	332
2021 Q4	$1.68M	Buy	15,002 +1,282	+9%	+$155K	0.03%	397
2021 Q3	$1.72M	Buy	13,720 +283	+2%	+$36.4K	0.03%	369
2021 Q2	$1.82M	Buy	13,437 +96	+0.7%	+$12.6K	0.03%	349
2021 Q1	$1.81M	Sell	13,341 -22,415	-63%	-$3.36M	0.04%	306
2020 Q4	$5.04M	Sell	35,756 -10,087	-22%	-$1.29M	0.12%	132
2020 Q3	$5.1M	Buy	45,843 +8,420	+22%	+$944K	0.08%	209
2020 Q2	$4.18M	Buy	37,423 +22,869	+157%	+$2.25M	0.12%	129
2020 Q1	$1.13M	Buy	+14,554	New	+$1.29M	0.03%	281

Other funds holding XBI

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Broadwater Capital Boston, Massachusetts $138M AUM 28.86% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Avantax Advisory Services's XBI Position: Q2 2025 in Review

Avantax Advisory Services reduced its State Street SPDR S&P Biotech ETF (XBI) stake by 34% in Q2 2025, selling an estimated $192K and leaving 4,723 shares worth $392K. The position accounts for ﹤0.01% of the portfolio, ranked #1730.

Avantax Advisory Services first reported a position in XBI in Q1 2020 and has held it in 22 quarters since. The position peaked at $5.1M in Q3 2020. 625 funds tracked by Wall St. Rank hold XBI as of Q2 2025.

Avantax Advisory Services held 4,723 shares of State Street SPDR S&P Biotech ETF worth $392K as of Q2 2025.
Avantax Advisory Services sold 2,401 State Street SPDR S&P Biotech ETF shares in Q2 2025, an estimated $192K.
State Street SPDR S&P Biotech ETF made up ﹤0.01% of Avantax Advisory Services's portfolio in Q2 2025, its #1730 holding.
Avantax Advisory Services first reported a position in State Street SPDR S&P Biotech ETF in Q1 2020 and has held it in 22 quarters since.
Avantax Advisory Services's State Street SPDR S&P Biotech ETF position peaked at $5.1M in Q3 2020.
625 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2025.

Based on Avantax Advisory Services's 13F filing for Q2 2025, filed 8 Aug 2025.